HDM1002
Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults
Huadong Medicine · Phase 2 · Status n/r · Enrollment 180
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| HDM1002 100mg BID | Obesity or overweight | 100mg | 12 | n/r | n/r |
| HDM1002 200mg BID | Obesity or overweight | 200mg | 12 | n/r | n/r |
| HDM1002 400mg QD | Obesity or overweight | 400mg | 12 | n/r | n/r |
| placebo | Obesity or overweight | n/r | 12 | n/r | n/r |